Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) FCF Margin (2022 - 2025)

Historic FCF Margin for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 171.27%.

  • bioAffinity Technologies' FCF Margin fell 981500.0% to 171.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 125.53%, marking a year-over-year decrease of 479300.0%. This contributed to the annual value of 78.44% for FY2024, which is 1608700.0% up from last year.
  • As of Q3 2025, bioAffinity Technologies' FCF Margin stood at 171.27%, which was down 981500.0% from 209.58% recorded in Q2 2025.
  • bioAffinity Technologies' FCF Margin's 5-year high stood at 65.09% during Q2 2024, with a 5-year trough of 169528.23% in Q1 2023.
  • Its 4-year average for FCF Margin is 29650.22%, with a median of 190.43% in 2025.
  • Per our database at Business Quant, bioAffinity Technologies' FCF Margin skyrocketed by 1694290200bps in 2024 and then plummeted by -1444900bps in 2025.
  • bioAffinity Technologies' FCF Margin (Quarter) stood at 55440.58% in 2022, then soared by 100bps to 72.42% in 2023, then dropped by -5bps to 75.97% in 2024, then crashed by -125bps to 171.27% in 2025.
  • Its FCF Margin stands at 171.27% for Q3 2025, versus 209.58% for Q2 2025 and 91.31% for Q1 2025.